Acceleron Pharma
(XLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -108,454 | -80,526 | -55,075 | -25,407 | -57,014 |
| Depreciation Amortization | 2,825 | 2,023 | 1,224 | 541 | 1,676 |
| Accounts receivable | -336 | 355 | 353 | -336 | 394 |
| Accounts payable and accrued liabilities | -504 | -566 | 71 | -778 | 644 |
| Other Working Capital | -331 | -10 | -1,662 | -3,613 | -494 |
| Other Operating Activity | 30,256 | 22,982 | 16,165 | 7,830 | 10,249 |
| Operating Cash Flow | $-76,544 | $-55,742 | $-38,924 | $-21,763 | $-44,545 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 86,001 | 50,221 | 33,533 | 112,889 |
| PPE Investments | -4,396 | -3,639 | -2,928 | -677 | -3,380 |
| Purchase Of Investment | -179,935 | -245 | -175 | -221 | -218,314 |
| Sale Of Investment | 119,965 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-64,366 | $82,117 | $47,118 | $32,635 | $-108,805 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 215,802 | 192,046 | 1,908 | 1,661 | 146,667 |
| Other Financing Activity | 4,494 | -226 | -140 | -140 | 0 |
| Financing Cash Flow | $220,296 | $191,820 | $1,768 | $1,521 | $146,667 |
| Beginning Cash Position | 21,896 | 21,896 | 21,896 | 21,896 | 28,579 |
| End Cash Position | 101,282 | 240,091 | 31,858 | 34,289 | 21,896 |
| Net Cash Flow | $79,386 | $218,195 | $9,962 | $12,393 | $-6,683 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,544 | -55,742 | -38,924 | -21,763 | -44,545 |
| Capital Expenditure | -4,396 | -3,639 | -2,928 | -677 | -3,380 |
| Free Cash Flow | -80,940 | -59,381 | -41,852 | -22,440 | -47,925 |